H2B1J_HUMAN - dbPTM
H2B1J_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID H2B1J_HUMAN
UniProt AC P06899
Protein Name Histone H2B type 1-J
Gene Name HIST1H2BJ
Organism Homo sapiens (Human).
Sequence Length 126
Subcellular Localization Nucleus. Chromosome.
Protein Description Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.; Has broad antibacterial activity. May contribute to the formation of the functional antimicrobial barrier of the colonic epithelium, and to the bactericidal activity of amniotic fluid..
Protein Sequence MPEPAKSAPAPKKGSKKAVTKAQKKDGKKRKRSRKESYSIYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSAK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MPEPAKSAP
------CCCCCCCCC
57.17-
6N6-crotonyl-L-lysine--MPEPAKSAPAPKK
--CCCCCCCCCCCCC
58.84-
6Acetylation--MPEPAKSAPAPKK
--CCCCCCCCCCCCC
58.8416283522
6Butyrylation--MPEPAKSAPAPKK
--CCCCCCCCCCCCC
58.8427105113
6Crotonylation--MPEPAKSAPAPKK
--CCCCCCCCCCCCC
58.8421925322
6Lactoylation--MPEPAKSAPAPKK
--CCCCCCCCCCCCC
58.8431645732
6Methylation--MPEPAKSAPAPKK
--CCCCCCCCCCCCC
58.8416283522
6Other--MPEPAKSAPAPKK
--CCCCCCCCCCCCC
58.8427105115
6Sumoylation--MPEPAKSAPAPKK
--CCCCCCCCCCCCC
58.8416283522
6Ubiquitination--MPEPAKSAPAPKK
--CCCCCCCCCCCCC
58.8416283522
7Phosphorylation-MPEPAKSAPAPKKG
-CCCCCCCCCCCCCC
41.4123401153
12N6-crotonyl-L-lysineAKSAPAPKKGSKKAV
CCCCCCCCCCCHHHH
72.39-
12AcetylationAKSAPAPKKGSKKAV
CCCCCCCCCCCHHHH
72.3916627869
12CrotonylationAKSAPAPKKGSKKAV
CCCCCCCCCCCHHHH
72.3921925322
12LactoylationAKSAPAPKKGSKKAV
CCCCCCCCCCCHHHH
72.3931645732
12OtherAKSAPAPKKGSKKAV
CCCCCCCCCCCHHHH
72.3927105115
13N6-crotonyl-L-lysineKSAPAPKKGSKKAVT
CCCCCCCCCCHHHHH
68.32-
13AcetylationKSAPAPKKGSKKAVT
CCCCCCCCCCHHHHH
68.3216283522
13CrotonylationKSAPAPKKGSKKAVT
CCCCCCCCCCHHHHH
68.3221925322
13OtherKSAPAPKKGSKKAVT
CCCCCCCCCCHHHHH
68.3224681537
15PhosphorylationAPAPKKGSKKAVTKA
CCCCCCCCHHHHHHH
39.601137958
16N6-crotonyl-L-lysinePAPKKGSKKAVTKAQ
CCCCCCCHHHHHHHH
54.11-
16AcetylationPAPKKGSKKAVTKAQ
CCCCCCCHHHHHHHH
54.1116283522
16CrotonylationPAPKKGSKKAVTKAQ
CCCCCCCHHHHHHHH
54.1121925322
16LactoylationPAPKKGSKKAVTKAQ
CCCCCCCHHHHHHHH
54.1131645732
17N6-crotonyl-L-lysineAPKKGSKKAVTKAQK
CCCCCCHHHHHHHHH
50.19-
17AcetylationAPKKGSKKAVTKAQK
CCCCCCHHHHHHHHH
50.1916627869
17CrotonylationAPKKGSKKAVTKAQK
CCCCCCHHHHHHHHH
50.1921925322
17GlutarylationAPKKGSKKAVTKAQK
CCCCCCHHHHHHHHH
50.1931542297
17LactoylationAPKKGSKKAVTKAQK
CCCCCCHHHHHHHHH
50.1931645732
17OtherAPKKGSKKAVTKAQK
CCCCCCHHHHHHHHH
50.1927105115
21N6-crotonyl-L-lysineGSKKAVTKAQKKDGK
CCHHHHHHHHHHCCC
42.07-
21AcetylationGSKKAVTKAQKKDGK
CCHHHHHHHHHHCCC
42.0716283522
21ButyrylationGSKKAVTKAQKKDGK
CCHHHHHHHHHHCCC
42.0727105113
21CrotonylationGSKKAVTKAQKKDGK
CCHHHHHHHHHHCCC
42.0721925322
21LactoylationGSKKAVTKAQKKDGK
CCHHHHHHHHHHCCC
42.0731645732
21OtherGSKKAVTKAQKKDGK
CCHHHHHHHHHHCCC
42.0727105115
21SumoylationGSKKAVTKAQKKDGK
CCHHHHHHHHHHCCC
42.0716283522
21UbiquitinationGSKKAVTKAQKKDGK
CCHHHHHHHHHHCCC
42.0716283522
24N6-crotonyl-L-lysineKAVTKAQKKDGKKRK
HHHHHHHHHCCCCCC
58.66-
24AcetylationKAVTKAQKKDGKKRK
HHHHHHHHHCCCCCC
58.6680401005
24CrotonylationKAVTKAQKKDGKKRK
HHHHHHHHHCCCCCC
58.6621925322
24LactoylationKAVTKAQKKDGKKRK
HHHHHHHHHCCCCCC
58.6631645732
24OtherKAVTKAQKKDGKKRK
HHHHHHHHHCCCCCC
58.6624681537
25OtherAVTKAQKKDGKKRKR
HHHHHHHHCCCCCCC
60.6824681537
33PhosphorylationDGKKRKRSRKESYSI
CCCCCCCCHHHHHHH
51.2210617636
35N6-crotonyl-L-lysineKKRKRSRKESYSIYV
CCCCCCHHHHHHHHH
52.86-
35AcetylationKKRKRSRKESYSIYV
CCCCCCHHHHHHHHH
52.8626051181
35CrotonylationKKRKRSRKESYSIYV
CCCCCCHHHHHHHHH
52.8621925322
35GlutarylationKKRKRSRKESYSIYV
CCCCCCHHHHHHHHH
52.8631542297
35OtherKKRKRSRKESYSIYV
CCCCCCHHHHHHHHH
52.8627105115
35SuccinylationKKRKRSRKESYSIYV
CCCCCCHHHHHHHHH
52.8622389435
35UbiquitinationKKRKRSRKESYSIYV
CCCCCCHHHHHHHHH
52.8621890473
37PhosphorylationRKRSRKESYSIYVYK
CCCCHHHHHHHHHHH
27.5022617229
38PhosphorylationKRSRKESYSIYVYKV
CCCHHHHHHHHHHHH
10.5228152594
39PhosphorylationRSRKESYSIYVYKVL
CCHHHHHHHHHHHHH
19.4021712546
41PhosphorylationRKESYSIYVYKVLKQ
HHHHHHHHHHHHHHH
7.5627155012
43PhosphorylationESYSIYVYKVLKQVH
HHHHHHHHHHHHHHC
4.3818180459
44AcetylationSYSIYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9225825284
44GlutarylationSYSIYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9231542297
44LactoylationSYSIYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9231645732
44OtherSYSIYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9224681537
44SuccinylationSYSIYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9223954790
44UbiquitinationSYSIYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9221890473
47AcetylationIYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9444491181
47GlutarylationIYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9431542297
47MethylationIYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9416627869
47OtherIYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9424681537
47SumoylationIYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9416627869
47UbiquitinationIYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9421906983
53PhosphorylationLKQVHPDTGISSKAM
HHHHCCCCCCCHHHH
40.6530266825
56PhosphorylationVHPDTGISSKAMGIM
HCCCCCCCHHHHHHH
27.4223401153
57PhosphorylationHPDTGISSKAMGIMN
CCCCCCCHHHHHHHH
23.6330266825
58"N6,N6-dimethyllysine"PDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.29-
58MethylationPDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.2916627869
58OtherPDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.2924681537
58UbiquitinationPDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.2921906983
65PhosphorylationKAMGIMNSFVNDIFE
HHHHHHHHHHHHHHH
17.1222617229
73MethylationFVNDIFERIAGEASR
HHHHHHHHHHHHHHH
17.20-
79PhosphorylationERIAGEASRLAHYNK
HHHHHHHHHHHHHCC
24.4322617229
80MethylationRIAGEASRLAHYNKR
HHHHHHHHHHHHCCC
42.83-
84PhosphorylationEASRLAHYNKRSTIT
HHHHHHHHCCCCCCC
19.4425884760
86"N6,N6,N6-trimethyllysine"SRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.33-
86AcetylationSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.33-
86LactoylationSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.3331645732
86MethylationSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.33-
86OtherSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.3327105115
86UbiquitinationSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.33-
87MethylationRLAHYNKRSTITSRE
HHHHHCCCCCCCHHH
35.08-
88PhosphorylationLAHYNKRSTITSREI
HHHHCCCCCCCHHHH
26.2730266825
89PhosphorylationAHYNKRSTITSREIQ
HHHCCCCCCCHHHHH
32.1030266825
91PhosphorylationYNKRSTITSREIQTA
HCCCCCCCHHHHHHH
23.0930266825
92PhosphorylationNKRSTITSREIQTAV
CCCCCCCHHHHHHHH
24.8623401153
93MethylationKRSTITSREIQTAVR
CCCCCCHHHHHHHHH
36.07-
97PhosphorylationITSREIQTAVRLLLP
CCHHHHHHHHHHHCC
32.5523403867
100MethylationREIQTAVRLLLPGEL
HHHHHHHHHHCCHHH
19.70-
109SumoylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHC
44.73-
109AcetylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHC
44.7366727957
109GlutarylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHC
44.7331542297
109LactoylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHC
44.7331645732
109MethylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHC
44.7316627869
109OtherLLPGELAKHAVSEGT
HCCHHHHHHHHHHHC
44.7324681537
109SumoylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHC
44.7316627869
109UbiquitinationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHC
44.7321906983
113O-linked_GlycosylationELAKHAVSEGTKAVT
HHHHHHHHHHCHHHH
30.96UniProtKB CARBOHYD
113PhosphorylationELAKHAVSEGTKAVT
HHHHHHHHHHCHHHH
30.9628176443
116PhosphorylationKHAVSEGTKAVTKYT
HHHHHHHCHHHHHHC
16.2720068231
117SumoylationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.28-
117AcetylationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.2822389435
117GlutarylationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.2831542297
117LactoylationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.2831645732
117MalonylationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.2822389435
117MethylationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.28-
117OtherHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.2827105115
117SuccinylationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.2822389435
117SumoylationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.2822389435
117UbiquitinationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.2822389435
120PhosphorylationSEGTKAVTKYTSAK-
HHHCHHHHHHCCCC-
24.1620068231
121SumoylationEGTKAVTKYTSAK--
HHCHHHHHHCCCC--
39.67-
121AcetylationEGTKAVTKYTSAK--
HHCHHHHHHCCCC--
39.6722389435
121GlutarylationEGTKAVTKYTSAK--
HHCHHHHHHCCCC--
39.6731542297
121LactoylationEGTKAVTKYTSAK--
HHCHHHHHHCCCC--
39.6731645732
121OtherEGTKAVTKYTSAK--
HHCHHHHHHCCCC--
39.6727105115
121SuccinylationEGTKAVTKYTSAK--
HHCHHHHHHCCCC--
39.6722389435
121SumoylationEGTKAVTKYTSAK--
HHCHHHHHHCCCC--
39.6722389435
121UbiquitinationEGTKAVTKYTSAK--
HHCHHHHHHCCCC--
39.6716627869
122PhosphorylationGTKAVTKYTSAK---
HCHHHHHHCCCC---
9.14-
123PhosphorylationTKAVTKYTSAK----
CHHHHHHCCCC----
24.6224719451
124PhosphorylationKAVTKYTSAK-----
HHHHHHCCCC-----
30.85-
126UbiquitinationVTKYTSAK-------
HHHHCCCC-------
61.72-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
15SPhosphorylationKinaseMST1P26927
Uniprot
15SPhosphorylationKinaseSTK4Q13043
GPS
37SPhosphorylationKinaseAMPKQ9Y478
Uniprot
37SPhosphorylationKinaseAKT1P31749
PSP
79SPhosphorylationKinaseAURKBQ96GD4
GPS
84YPhosphorylationKinaseAURKBQ96GD4
GPS
-KUbiquitinationE3 ubiquitin ligaseDTX3LQ8TDB6
PMID:26479788

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
4KMethylation

16627869
4KMethylation

16627869
4Kubiquitylation

16627869
4Kubiquitylation

16627869
15SPhosphorylation

12757711
15SPhosphorylation

12757711
35KMethylation

21925322
35Kubiquitylation

21925322
37SPhosphorylation

12757711
79KMethylation

11709551
79KMethylation

11709551
79Kubiquitylation

11709551
79Kubiquitylation

11709551
113Subiquitylation

-
121Kubiquitylation

16627869
121Kubiquitylation

16627869
121KMethylation

16627869

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of H2B1J_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TLX3_HUMANTLX3physical
20211142
JMJD6_HUMANJMJD6physical
23455924
PARP9_HUMANPARP9physical
26479788
DTX3L_HUMANDTX3Lphysical
26479788
STAT1_HUMANSTAT1physical
26479788
FIBA_HUMANFGAphysical
28514442
FIBB_HUMANFGBphysical
28514442
FIBG_HUMANFGGphysical
28514442
HBB_HUMANHBBphysical
28514442
UBP48_HUMANUSP48physical
28514442
MDM2_HUMANMDM2physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of H2B1J_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey.";
Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
Mol. Cell 23:607-618(2006).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-6; LYS-12; LYS-13; LYS-16;LYS-17; LYS-21; LYS-24 AND LYS-109, AND MASS SPECTROMETRY.
"Inhibition of core histones acetylation by carcinogenic nickel(II).";
Golebiowski F., Kasprzak K.S.;
Mol. Cell. Biochem. 279:133-139(2005).
Cited for: ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21.
"Quantitative proteomic analysis of post-translational modificationsof human histones.";
Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M.,Finn P., Grauslund M., Hansen A.M., Jensen O.N.;
Mol. Cell. Proteomics 5:1314-1325(2006).
Cited for: PROTEIN SEQUENCE OF 7-24, ACETYLATION AT LYS-6; LYS-12; LYS-13;LYS-16; LYS-17 AND LYS-21, METHYLATION AT LYS-47; LYS-58 AND LYS-109,UBIQUITINATION AT LYS-121, AND MASS SPECTROMETRY.
Methylation
ReferencePubMed
"Quantitative proteomic analysis of post-translational modificationsof human histones.";
Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M.,Finn P., Grauslund M., Hansen A.M., Jensen O.N.;
Mol. Cell. Proteomics 5:1314-1325(2006).
Cited for: PROTEIN SEQUENCE OF 7-24, ACETYLATION AT LYS-6; LYS-12; LYS-13;LYS-16; LYS-17 AND LYS-21, METHYLATION AT LYS-47; LYS-58 AND LYS-109,UBIQUITINATION AT LYS-121, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Apoptotic phosphorylation of histone H2B is mediated by mammaliansterile twenty kinase.";
Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.;
Cell 113:507-517(2003).
Cited for: PHOSPHORYLATION AT SER-15.
Ubiquitylation
ReferencePubMed
"Histone H2B monoubiquitination functions cooperatively with FACT toregulate elongation by RNA polymerase II.";
Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A.,Reinberg D.;
Cell 125:703-717(2006).
Cited for: UBIQUITINATION AT LYS-121.
"Monoubiquitination of human histone H2B: the factors involved andtheir roles in HOX gene regulation.";
Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H.,Tempst P., Reinberg D.;
Mol. Cell 20:601-611(2005).
Cited for: UBIQUITINATION AT LYS-121.
"Quantitative proteomic analysis of post-translational modificationsof human histones.";
Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M.,Finn P., Grauslund M., Hansen A.M., Jensen O.N.;
Mol. Cell. Proteomics 5:1314-1325(2006).
Cited for: PROTEIN SEQUENCE OF 7-24, ACETYLATION AT LYS-6; LYS-12; LYS-13;LYS-16; LYS-17 AND LYS-21, METHYLATION AT LYS-47; LYS-58 AND LYS-109,UBIQUITINATION AT LYS-121, AND MASS SPECTROMETRY.

TOP